NO20022973L - Oksazolidinoner som har en sulfoksiminfunksjonalitet - Google Patents

Oksazolidinoner som har en sulfoksiminfunksjonalitet

Info

Publication number
NO20022973L
NO20022973L NO20022973A NO20022973A NO20022973L NO 20022973 L NO20022973 L NO 20022973L NO 20022973 A NO20022973 A NO 20022973A NO 20022973 A NO20022973 A NO 20022973A NO 20022973 L NO20022973 L NO 20022973L
Authority
NO
Norway
Prior art keywords
oxazolidinones
sulfoximine
functionality
sulfoximine functionality
Prior art date
Application number
NO20022973A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022973D0 (no
Inventor
Jr Jackson B Hester
David L Alexander
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20022973D0 publication Critical patent/NO20022973D0/no
Publication of NO20022973L publication Critical patent/NO20022973L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022973A 1999-12-21 2002-06-20 Oksazolidinoner som har en sulfoksiminfunksjonalitet NO20022973L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17191699P 1999-12-21 1999-12-21
PCT/US2000/032451 WO2001046185A1 (en) 1999-12-21 2000-12-12 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents

Publications (2)

Publication Number Publication Date
NO20022973D0 NO20022973D0 (no) 2002-06-20
NO20022973L true NO20022973L (no) 2002-08-20

Family

ID=22625632

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022973A NO20022973L (no) 1999-12-21 2002-06-20 Oksazolidinoner som har en sulfoksiminfunksjonalitet

Country Status (22)

Country Link
US (1) US20010046987A1 (zh)
EP (1) EP1242417A1 (zh)
JP (1) JP2003518117A (zh)
KR (1) KR20020067557A (zh)
CN (1) CN1221548C (zh)
AR (1) AR029211A1 (zh)
AU (1) AU782078B2 (zh)
BR (1) BR0016605A (zh)
CA (1) CA2389482A1 (zh)
CO (1) CO5251427A1 (zh)
CZ (1) CZ20022142A3 (zh)
EA (1) EA005567B1 (zh)
HU (1) HUP0203869A2 (zh)
IL (1) IL150348A0 (zh)
MX (1) MXPA02006233A (zh)
NO (1) NO20022973L (zh)
NZ (1) NZ519725A (zh)
PE (1) PE20010931A1 (zh)
PL (1) PL356478A1 (zh)
SK (1) SK7572002A3 (zh)
WO (1) WO2001046185A1 (zh)
ZA (1) ZA200204166B (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
ES2268011T3 (es) * 2001-04-07 2007-03-16 Astrazeneca Ab Oxazolidinonas que contienen un grupo sulfonimida como antibioticos.
GB0108794D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compound
GB0108793D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
GB0108764D0 (en) * 2001-04-07 2001-05-30 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
TW200403240A (en) 2002-06-28 2004-03-01 Upjohn Co Difluorothioacetamides of oxazolidinones as antibacterial agents
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
WO2004089943A1 (en) 2003-04-09 2004-10-21 Pharmacia & Upjohn Company Llc Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US7265140B2 (en) * 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
WO2006056877A2 (en) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Diazepine oxazolidinones as antibacterial agents
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE602006010702D1 (de) 2005-06-29 2010-01-07 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
SG166126A1 (en) 2005-10-04 2010-11-29 Bayer Schering Pharma Ag Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo- 3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102007028319A1 (de) * 2007-06-20 2008-12-24 Bayer Healthcare Ag Substituierte Oxazolidinone und ihre Verwendung
WO2021184339A1 (en) * 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
ES2193201T3 (es) * 1994-11-15 2003-11-01 Upjohn Co Agentes antibacterianos tipo oxazolidonas sustituidas con oxazina y tiazina biciclica.
RU2175324C2 (ru) * 1995-09-01 2001-10-27 Фармация Энд Апджон Компани Фенилоксазолидиноны, имеющие с-с-связь с 4-8-членными гетероциклическими кольцами
ATE293609T1 (de) * 1997-05-30 2005-05-15 Upjohn Co Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität

Also Published As

Publication number Publication date
KR20020067557A (ko) 2002-08-22
PE20010931A1 (es) 2001-08-29
MXPA02006233A (es) 2002-12-05
EA200200699A1 (ru) 2003-02-27
AR029211A1 (es) 2003-06-18
ZA200204166B (en) 2003-10-29
WO2001046185A1 (en) 2001-06-28
PL356478A1 (en) 2004-06-28
EA005567B1 (ru) 2005-04-28
SK7572002A3 (en) 2002-12-03
IL150348A0 (en) 2002-12-01
CN1391572A (zh) 2003-01-15
NO20022973D0 (no) 2002-06-20
US20010046987A1 (en) 2001-11-29
CA2389482A1 (en) 2001-06-28
JP2003518117A (ja) 2003-06-03
HUP0203869A2 (hu) 2003-07-28
CN1221548C (zh) 2005-10-05
AU2050201A (en) 2001-07-03
AU782078B2 (en) 2005-06-30
EP1242417A1 (en) 2002-09-25
NZ519725A (en) 2004-05-28
CO5251427A1 (es) 2003-02-28
BR0016605A (pt) 2003-02-25
CZ20022142A3 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
NO20022973L (no) Oksazolidinoner som har en sulfoksiminfunksjonalitet
NO20051688D0 (no) Farmasoytiske blandinger som har en modifisert baerer
IT1318317B1 (it) Dispensatore a doppia funzione
DE60314124D1 (de) 2-(2,6-dichlorphenyl)-diarylimidazole
DE50007817D1 (de) Mikrospiegel
NL1014872A1 (nl) Aandrijving.
NO20000693D0 (no) Festeanordning
NO20015078L (no) Sulfonamidderivater som har oksadiazolringer
NO20041165L (no) Avstengningsanordning.
DK1026405T3 (da) Fastgørelsesanordning
ITTO20030507A1 (it) Premistoppa a tenuta di fango.
ITMI20002078A0 (it) Pompa a doppia membrana - compatta
NO20041455L (no) Zirkonium-/metalloksidfibrer.
DE60208495D1 (de) Kontrastphantom
IT1309591B1 (it) Composizioni a rilascio controllato di betaistina.
DE60111415D1 (de) Nagelschneider
DE50010321D1 (de) Emulgatoren
FR2802198B1 (fr) Machine a sections individuelles
DE502004004887D1 (de) Zangenaggregat einer kämmaschine
DE50004387D1 (de) Schliessvorrichtung
IT1318610B1 (it) Micomelanine a struttura polinaftoica.
DE59912578D1 (de) Turbomaschinenschaufel
FR2794251B1 (fr) Miroir a membrane deformable
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
ITMO990082A0 (it) Mezzi a gancio.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application